PlainRecalls
FDA Drug Moderate Class II Terminated

KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

Reported: August 14, 2019 Initiated: June 19, 2019 #D-1670-2019

Product Description

KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
RXQ Compounding LLC
Units Affected
N/A
Distribution
Nationwide USA
Location
Athens, OH

Frequently Asked Questions

What product was recalled?
KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.. Recalled by RXQ Compounding LLC. Units affected: N/A.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2019. Severity: Moderate. Recall number: D-1670-2019.